International Immunology, Vol 10, 943-950, Copyright © 1998 by Oxford University Press
MJ van Stipdonk, AA Willems, S Amor, C Persoon-Deen, PJ Travers, CJ Boog and JM van Noort
Factors such as developmental stage or physiological and infectious stress
may change patterns of post-translational protein modification. In order to
determine whether such regulated types of modification may influence T cell
responsiveness to self proteins we examined the T cell response of SJL
(H-2s) mice to alphaB-crystallin, a small heat shock protein that can exist
in differentially phosphorylated forms. Epitope mapping revealed the
presence of two T cell epitopes that are presented by I-As. One major
epitope including residues 41-56 contains an amino acid residue (Ser45)
that can be phosphorylated as the result of aging or stress. Accordingly, T
cells from SJL mice discriminate between preparations of alphaB-crystallin
that differ in their extent of phosphorylation at the level of whole
protein as well as at the level of determinant-specific responses.
Phosphorylation at Ser45 does not prevent binding of the peptide 41-56 to
I-As and computer-assisted modelling of the peptide-MHC complex suggests
that the phosphate group of the bound peptide extends outwards from the
peptide-binding cleft and may thus be available for direct contact with
TCR. Together, our data provide evidence that stress-inducible
phosphorylation of alphaB- crystallin creates neo-determinants for T cells
and, therefore, may contribute to the breakdown of peripheral tolerance to
this self protein.
ARTICLES
T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen
Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. R. Depontieu, J. Qian, A. L. Zarling, T. L. McMiller, T. M. Salay, A. Norris, A. M. English, J. Shabanowitz, V. H. Engelhard, D. F. Hunt, et al. Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy PNAS, July 21, 2009; 106(29): 12073 - 12078. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, P. C. Chien Jr., M. Tuen, M. L. Visciano, S. Cohen, S. Blais, C.-F. Xu, H.-T. Zhang, and C. E. Hioe Identification of an N-Linked Glycosylation in the C4 Region of HIV-1 Envelope gp120 That Is Critical for Recognition of Neighboring CD4 T Cell Epitopes J. Immunol., March 15, 2008; 180(6): 4011 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Pedersen, A. J. Sloane, S. S. Prasad, L. T. Sebastian, R. A. Lindner, M. Hsu, M. Robinson, P. T. Bye, R. P. Weinberger, and J. L. Harry An Immunoproteomic Approach for Identification of Clinical Biomarkers for Monitoring Disease: Application to Cystic Fibrosis Mol. Cell. Proteomics, August 1, 2005; 4(8): 1052 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herzog, Y. Maekawa, T. P. Cirrito, B. S. Illian, and E. R. Unanue Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells PNAS, May 31, 2005; 102(22): 7928 - 7933. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. C. Leung, C. Quan, O. Park, J. Van de Water, M. J. Kurth, M. H. Nantz, A. A. Ansari, R. L. Coppel, K. S. Lam, and M. E. Gershwin Immunization with a Xenobiotic 6-Bromohexanoate Bovine Serum Albumin Conjugate Induces Antimitochondrial Antibodies J. Immunol., May 15, 2003; 170(10): 5326 - 5332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vlad, S. Muller, M. Cudic, H. Paulsen, L. Otvos Jr., F.-G. Hanisch, and O. J. Finn Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells: Processing of Tumor Antigen MUC1 Glycopeptides for Presentation to Major Histocompatibility Complex Class II-restricted T Cells J. Exp. Med., December 2, 2002; 196(11): 1435 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Banwell and A. G. Engel {alpha}B-Crystallin immunolocalization yields new insights into inclusion body myositis Neurology, March 14, 2000; 54(5): 1033 - 1041. [Abstract] [Full Text] [PDF] |
||||




